Does China’s competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine

With the National Centralized Drug Procurement policy gradually applied nationally in China, concerns about the effectiveness and safety of bid-winning generic drugs are growing again, but relevant studies are lacking. This real-world, before-and-after study was conducted to explore the clinical eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Ding, Yudan, Wu, Zhenzhen, Wang, Juan, Wu, Xiangping, Xie, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999380/
https://www.ncbi.nlm.nih.gov/pubmed/36909190
http://dx.doi.org/10.3389/fphar.2023.1097600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999380/
https://www.ncbi.nlm.nih.gov/pubmed/36909190
http://dx.doi.org/10.3389/fphar.2023.1097600

Ejemplares similares